# SITAGLIPTIN
> **ANDA216337** · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMACEUTICALS INC · Approved 2025-03-06
## Drug
- **FDA Application Number:** ANDA216337
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SITAGLIPTIN
- **Generic name:** Sitagliptin
- **Active ingredients:** SITAGLIPTIN
- **Dosage form:** TABLET
- **Route:** FILM COATED
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** SCIEGEN PHARMACEUTICALS INC
- **First approval:** 2025-03-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216337)
---
*MORVS · CC0 1.0*